Edelweiss Mutual FundEquity Scheme - Mid Cap Fund9.9 years
The scheme aims to generate long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of Mid Cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer ITI Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
9.9 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.69% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -39.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Sumanta Khan · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 22.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 39%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
15 Jan 2018 – 13 Nov 2020
Trough 23 Mar 2020 · recovered in 235 days
-39.2%
16 Dec 2024 – 30 Jun 2025
Trough 28 Feb 2025 · recovered in 122 days
-20.1%
18 Oct 2021 – 30 Aug 2022
Trough 20 Jun 2022 · recovered in 71 days
-19.0%
7 Jan 2026 – 6 May 2026
Trough 23 Mar 2026 · recovered in 44 days
-12.8%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
51
Consistency
94
Risk-adjusted
64
Drawdown
2
Mean
62
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 106 holdings · top 10 are 22.6%.
Others CBLO
Unspecified
3.1%
The Federal Bank Ltd
Financial
3.1%
Multi Commodity Exchange Of India Ltd
Financial
2.7%
Solar Industries India Ltd
Materials
2.1%
City Union Bank Ltd
Financial
2.0%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
ITI Mutual Fund
Caveat: Higher TER · Lower trailing returns
Axis Mutual Fund
Caveat: Higher TER · Lower trailing returns
Baroda BNP Paribas Mutual Fund
Caveat: Higher TER · Lower trailing returns
DSP Mutual Fund
Caveat: Higher TER · Lower trailing returns
Franklin Templeton Mutual Fund
Caveat: Higher TER · Lower trailing returns
Edelweiss Mutual FundEquity Scheme - Mid Cap Fund9.9 years
The scheme aims to generate long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of Mid Cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer ITI Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
9.9 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.69% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -39.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Sumanta Khan · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 22.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 39%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
30 Oct 2026 · -2.0% over 1Y
118.956
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-9.8%
15 Jan 2018 – 13 Nov 2020
Trough 23 Mar 2020 · recovered in 235 days
-39.2%
16 Dec 2024 – 30 Jun 2025
Trough 28 Feb 2025 · recovered in 122 days
-20.1%
18 Oct 2021 – 30 Aug 2022
Trough 20 Jun 2022 · recovered in 71 days
-19.0%
7 Jan 2026 – 6 May 2026
Trough 23 Mar 2026 · recovered in 44 days
-12.8%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
51
Consistency
94
Risk-adjusted
64
Drawdown
2
Mean
62
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 106 holdings · top 10 are 22.6%.
Others CBLO
Unspecified
3.1%
The Federal Bank Ltd
Financial
3.1%
Multi Commodity Exchange Of India Ltd
Financial
2.7%
Solar Industries India Ltd
Materials
2.1%
City Union Bank Ltd
Financial
2.0%